INTRODUCTION 1 2
Dental caries is defined as the localized destruction of susceptible dental hard 3 tissues by acidic by-products from bacterial fermentation of dietary carbohydrates 4 (25) . Overpopulation of the oral cavity by acid-producing bacteria is one of the 5 three main pathological factors highlighted in the cariogenic process (6) . 6
Therefore, an important strategy to control or even eradicate dental caries is to 7 target the bacterial aspect of the disease (5) . Successful antimicrobial therapy 8 against cariogenic bacteria largely depends on two major factors at the hard-9 tissue level: the specificity of the chemotherapeutic agent and the maintenance 10 of its effective local concentration. Given that most of the available antimicrobial 11 compounds do not have hard tissue specificity (19), it is critical to develop 12 mechanisms for retaining these antimicrobials at the tooth surface, thereby 13 maintaining their effective local concentration and improving their antimicrobial 14
efficacy (4, 16). 15 16
Various delivery systems have been developed to maintain drug concentration in 17 the oral cavity. These include bioadhesive tablets (1, 7, 18), bioadhesive 18 patches/films (22, 26), and bioadhesive gels and semisolids (10, 24, 29) . 19
However, these formulations provide the highest drug concentration at mucosal 20 epithelia instead of the tooth surface. Furthermore, local irritation at the site of 21 adhesion and the uncomfortable sensation of a foreign object often lead to poor 22 patient compliance (20, 27) . To bring direct and long-lasting interaction of 23 on October 2, 2017 by guest http://aac.asm.org/ Downloaded from dissolved in DCM, washed with water (2 × 10 mL) and brine (2 × 10 mL) and 1 then dried over anhydrous magnesium sulfide. After removal of the solvent 2 under vacuum, the product was obtained. The yield of polymer was 96.2%. 
Synthesis of Pluronic
® 123-alendronate conjugate (ALN-P123, 5). Azido-8 P123 (2.9 g, 0.5 mmol) and 1-hydroxy-4-pent-4-ynamidobutane-1,1-9 diyldiphosphonic acid (0.395 g, 1 mmol) were dissolved in EtOH/H 2 O solution 10
(1/1, 15 mL). Sodium ascorbate (0.198 g, 1 mmol) and copper sulfide 11 pentahydrate (25 mg, 0.1mmol) were then added separately under argon. The 12 reaction mixture was allowed to stir for 3 days at room temperature. After 13 removal of the solvent, the product was acidified and purified with a LH-20 14 column using methanol as the eluent. The yield of the polymeric product was 15 70%. The conversion ratio from azide to alendronate at P123 chain termini was 16 growth at 37°C and 5% CO 2 , a single colony of bacteria was inoculated into 3 mL 15 of THYE broth (2) and allowed to grow statically overnight at 37°C and 5% CO 2 . 16
The next day, the overnight culture was diluted to a density of 2×10 4 CFU/mL in 17 chemically-defined media containing 0.25% w/v of glucose and sucrose (CDM), 18 prepared as previously described (2). group, discs were dip-washed 3 times with ethanol and then followed by washing 2 with CDM. The HA discs were then transferred to wells containing 1 mL of the 3 diluted S. mutans, and cultured statically for 48 hr to allow biofilm growth at 37°C 4 with 5% CO 2 . CDM was changed at 24 hr. 5
6
After 48 hours growth, the HA discs were dip-washed 3 times in THYE media to 7 remove loosely attached bacteria and then placed in 1 mL of THYE media. The 8 surfaces of HA discs were gently scraped with a sterile spatula to harvest 9 adherent cells, and the number of viable cells in each sample was quantified 10 using the track dilution method (9) to achieve countable colony-forming units 11 (CFUs). All plates were incubated for 48 hr at 37°C with 5% CO 2 prior to 12 counting colonies. These experiments were repeated three times. 13
14

Statistical Analysis 15
The Kruskal-Wallis test, a nonparametric alternative to one-way analysis of 16 variance that does not assume that data follow normal distribution, was used for 17 overall comparison of the mean ranks of the CFUs under different types of 18 treatments. To evaluate specific differences between experimental groups, the 19 Tukey's nonparametric multiple comparison method was used; p < 0.05 was 20 considered as significant in both tests. (Table 1) suggest that both empty micelles 10 and farnesol loaded non-binding micelles had the biggest particle size (~100 nm). 11
Farnesol loaded tooth-binding micelles had a relatively smaller size, which 12 increased as the farnesol loading was raised. In the loading range tested, 13 however, the D eff of farnesol loaded tooth-binding micelles is < 100 nm. The purpose of this study was to develop a simple yet efficient drug delivery 4 system that would maintain a long-lasting effective concentration of drug on the 5 tooth surface. Such an approach, in combination with potent antimicrobials, may 6 effectively prevent biofilm formation on the tooth surface by cariogenic bacteria 7 such as S. mutans, and subsequent development of dental caries. The important 8 and novel element of this delivery system is the introduction of a tooth-binding 9 moiety that would anchor the delivery system of choice onto the tooth surface. 10 11 Alendronate, a bisphosphonate, was chosen as a prototype binding moiety 12 because of its high affinity for hydroxyapatite crystals (the main component of 13 tooth enamel), and the fact that it has been used clinically for the treatment of 14 osteoporosis for many years (23). However, a potential risk of alendronate 15 usage in an oral rinse formulation would be the systemic ingestion of the drug. 16
Concerns have been raised about the long-term impact of bisphosphonates on 17 bone resorptive activity and its rare association with osteonecrosis of the jaw (3). 18
These risks would likely be minimal with a mouth rinse formulation using the 19 micellar delivery system described here, due to (1) the chemical conjugation of 20 alendronate to the chain termini of Pluronic  and (2) the expectoration of the vast 21 majority of the formulation, which would result in a very low systemic dose. Farnesol is a hydrophobic compound with a water solubility of merely 1.2 mM (8) . 5 In previous investigations, organic solvents (ethanol and DMSO) were required to 6 assist the dissolution of farnesol in water (12-14). Using the Pluronic ® block 7 copolymers, which can readily self-assemble into micelles in aqueous solutions 8 with a core (hydrophobic)-shell (hydrophilic) structure, farnesol can be 9 encapsulated into the hydrophobic core of Pluronic ® micelle (PPO segment) 10 which acts as the hosting reservoir that dissolves and readily disperses the 11 hydrophobic farnesol in water. Therefore, the benefits of this formulation may 12 also include the prevention of irritation caused by organic solvents, and 13 potentially-improved patient compliance. 14 15
The binding kinetics of the tooth-binding micelles, as demonstrated in Figure 2 , 16
indicates that even at relatively low binding moiety content, these micelles exhibit 17 swift binding kinetics to HA particles. Additional studies will be performed in the 18 future to clarify the impact of other in vivo factors (e.g. salivary pellicle) on the 19 binding kinetics of these micelles. The small size (~ 100 nm) of the micelles 20 developed in this study may also facilitate their ability to access locations on and 21 between teeth that normal tooth-brushing misses and are unlikely to cause 22 uncomfortable foreign object sensations in patients. As shown in Figure 3 This work was supported in part by NIH grants AR053325 (DW) and AI038901 7 (KWB). We also acknowledge Dr. James Booth for the helpful discussion at the 8 beginning of the project. 
